مشخصات مقاله | |
عنوان مقاله | What exactly IS Martin Shkreli? |
ترجمه عنوان مقاله | مارتین شکرلی دقیقا کیست؟ |
فرمت مقاله | |
نوع مقاله | ISI |
سال انتشار | |
تعداد صفحات مقاله | 6 صفحه |
رشته های مرتبط | مدیریت |
گرایش های مرتبط | مدیریت کسب و کار MBA ، کارآفرینی |
مجله | افق های تجارت – Business Horizons |
کلمات کلیدی | دانشکده کسب و کار آیوی، دانشگاه غربی، کانادا |
کد محصول | E4726 |
تعداد کلمات | 2897 کلمه |
نشریه | نشریه الزویر |
لینک مقاله در سایت مرجع | لینک این مقاله در سایت الزویر (ساینس دایرکت) Sciencedirect – Elsevier |
وضعیت ترجمه مقاله | ترجمه آماده این مقاله موجود نمیباشد. میتوانید از طریق دکمه پایین سفارش دهید. |
دانلود رایگان مقاله | دانلود رایگان مقاله انگلیسی |
سفارش ترجمه این مقاله | سفارش ترجمه این مقاله |
بخشی از متن مقاله: |
To be clear: We’re notsaying that Martin Shkreli is not an entrepreneur because he is someone we cannot admire or because his avarice scales the heights. Instead, we are saying that Mr. Shkreli is not an entrepreneur because his actions are not entrepreneurial for at least two reasons.
First: Shkreli may have started a company, but he created nothing, innovated nothing, offered nothing new, and solved nothing. Instead, he repriced existing products to extort the value created by others–—the original innovators of the drugs–—at the expense of patients who needed these drugs, the insurance companies that paid for them, and other insurance customers who will probably end up paying higher premiums as a result of Mr. Shkreli’s actions. From this point of view, Mr. Shkreli seems to be a rent-seeker: someone who seeks to acquire personal wealth without creating new wealth. Second: The fact that patients paid exorbitantly higher prices for the same drugs neither implies that the market undervalued the drugs nor suggests that Mr. Shkreli’s actions had an equilibrating effect on the market, a key economic function often attributed to entrepreneurs. Rather, the fact that patients paid the inflated prices simply reflects Shkreli’s manipulation of a highly inelastic demand for monopolized pharmaceutical products. This brings up a significant albeit theoretical point: Scholars such as Frank Knight have long described entrepreneurs as the bearers of uncertainty. In our interpretation, Mr. Shkreli faced little uncertainty because he knew that those desperate fortheirtreatments would certainly accept much higher prices. While some may question why we refuse to label Mr. Shkreli’s actions as entrepreneurial, we argue that the distinction is important because in the public sphere it has become increasingly common to celebrate the achievements of entrepreneurs and to encourage others to follow suit. Indeed, millennials may well be the most entrepreneurial-minded generation ever, but whom do we want them to emulate? |